Correspondence | Published:

Hearing loss and tinnitus—are funders and industry listening?

Nature Biotechnology volume 31, pages 972974 (2013) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Nat. Biotechnol. 31, 575–576 (2013).

  2. 2.

    et al. Lancet 380, 2129–2143 (2012).

  3. 3.

    Anonymous. Lancet 378, 99 (2011).

  4. 4.

    , & Diabetes Care 21, 1414–1431 (1998).

  5. 5.

    , & Lancet 378, 169–181 (2011).

  6. 6.

    & Expert Opin. Pharmacother. 13, 2495–2509 (2012).

  7. 7.

    , & Am. J. Med. 123, 711–718 (2010).

  8. 8.

    , , , & PLoS ONE 7, e29966 (2012).

  9. 9.

    et al. BMC Health Serv. Res. 11, 302 (2011).

  10. 10.

    , & Tinnitus. Lancet (2 July 2013).

  11. 11.

    et al. Nat. Med. 2, 1338–1343 (1996).

  12. 12.

    , , & Proc. Natl. Acad. Sci. USA 97, 7597–7602 (2000).

  13. 13.

    , , , & J. Comp. Neurol. 341, 241–256 (1994).

  14. 14.

    , , , & Neuropharmacology 39, 1959–1973 (2000).

  15. 15.

    et al. J. Neurosci. 23, 3944–3952 (2003).

  16. 16.

    et al. J. Neurosci. 28, 7313–7323 (2008).

  17. 17.

    & Nat. Neurosci. 5, 147–154 (2002).

  18. 18.

    & Proc. Natl. Acad. Sci. USA 103, 5537–5542 (2006).

  19. 19.

    et al. Nature 470, 101–104 (2011).

  20. 20.

    et al. Proc. Natl. Acad. Sci. USA 108, 7601–7606 (2011).

  21. 21.

    , , , & Proc. Natl. Acad. Sci. USA 108, 14974–14979 (2011).

  22. 22.

    , & Proc. Natl. Acad. Sci. USA 110, 9980–9985 (2013).

Download references

Acknowledgements

The authors would like to thank all organizations mentioned in this article that shared their expenditures, as well as the Hudspeth laboratory for invaluable support. C.R.C. is a recipient of post-doctoral fellowships from the Swiss National Science Foundation (SNF) nþ PBGEP3-125837 and the Schweizerischen Stiftung für medizinisch-biologische Stipendien (SSMBS) nþ PASMP3-136979 and has received funding from the Wenner Gren, Lars Hiertas Minne, Magnus Bergvalls Stiftelserna and Tysta Skolan. B.C. has received funding from the Vetenskapsrådet (VR), Forskningsrådet för arbetsliv och socialvetenskap (FAS), Karolinska Institutet and Tysta Skolan. B.L. has received research funding from the Tinnitus Research Initiative (TRI), the American Tinnitus Association (ATA), the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium für Bildung und Forschung (BMBF), AztraZeneca and Cerbomed. This article reflects the authors' personal opinions and not those of the cited organizations.

Author information

Affiliations

  1. Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.

    • Christopher R Cederroth
    •  & Barbara Canlon
  2. University of Regensburg, Department of Psychiatry and Psychotherapy, and Tinnitus Research Initiative, Regensburg, Germany.

    • Berthold Langguth

Authors

  1. Search for Christopher R Cederroth in:

  2. Search for Barbara Canlon in:

  3. Search for Berthold Langguth in:

Competing interests

B.L. has received honoraria and speakers' fee from ANM, AztraZeneca, Autifony, Lundbeck, Merz, Magventure, Novartis, Pfizer and Servier, and travel and accommodation payments from Lilly, Servier and Pfizer. B.L. is a member of the executive board of the Tinnitus Research Initiative.

Corresponding author

Correspondence to Christopher R Cederroth.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.2736

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing